2022 annual financial data
Cartesian Therapeutics 2022 Operating margin
Cartesian Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was 13.12%.
Operating income was 14,538,000 USD and net income was 35,379,000 USD.
Operating cash flow was -31,631,000 USD.
Get free Cartesian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 110,777,000 USD
- Operating income
- 14,538,000 USD
- Net income
- 35,379,000 USD
- Operating cash flow
- -31,631,000 USD